UBS upgraded Life360 stock from Neutral to Buy and increased its price target from $52.00 to $55.00, adding to the bullish analyst consensus with targets ranging from $50 to $58. Currently trading at ...

UBS analyst Thiago Batista upgraded Itau Unibanco stock, traded on the B3 under the ticker ITUB4:BZ and on the NYSE as ITUB, ...

UBS analyst Joseph Spak raised the firm’s price target on Mobileye (MBLY) to $17 from $14 and keeps a Neutral rating on the ...

As per the channel Check, APL's growth momentum is likely to remain, aided by customers shifting from refurbished steel to ...

UBS lowered the firm’s price target on Yeti (YETI) to $43 from $44 and keeps a Neutral rating on the shares. Sentiment around Consumer Staples ...

ZURICH (Reuters) -UBS could be seen as being too big for Switzerland following its takeover of Credit Suisse, former Swiss Finance Minister Ueli Maurer said on Saturday, with measures needed to ...

According to UBS, APL Apollo Tubes is poised to sustain its growth momentum, driven by increased customer adoption of ...

The broking firm raised the target price of SBI Cards to ₹800 from ₹600, a potential upside of 6% from Thursday's closing ...

UBS analyst Peter Grom lowered the firm’s price target on Molson Coors (TAP) to $58 from $60 and keeps a Neutral rating on the shares.

Investing.com -- UBS analysts have reaffirmed their bullish stance on Continental (ETR: CONG) stock, emphasizing the ...

Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...